Orbis Allan Gray’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-37,274
Closed -$3.79M – 83
2015
Q4
$3.79M Sell
37,274
-17,364
-32% -$1.95M 0.03% 69
2015
Q3
$9.7M Sell
54,638
-2,960
-5% -$690K 0.08% 65
2015
Q2
$12.8M Sell
57,598
-32,220
-36% -$7.14M 0.1% 66
2015
Q1
$17.8M Sell
89,818
-2,158,251
-96% -$383M 0.14% 57
2014
Q4
$322M Sell
2,248,069
-21,144
-0.9% -$2.84M 2.45% 12
2014
Q3
$298M Sell
2,269,213
-1,571,208
-41% -$187M 2.36% 14
2014
Q2
$484M Buy
3,840,421
+834,721
+28% +$106M 3.99% 7
2014
Q1
$396M Sell
3,005,700
-478,317
-14% -$65.4M 3.14% 9
2013
Q4
$409M Sell
3,484,017
-529,179
-13% -$58M 2.83% 10
2013
Q3
$419M Sell
4,013,196
-115,854
-3% -$11.3M 3.15% 11
2013
Q2
$355M Hold
4,129,050
– – 2.83% 10

Other funds holding BHC

Orbis Allan Gray's BHC Position: Q1 2016 in Review

Orbis Allan Gray sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 37,274 shares — an estimated $3.79M sold.

Orbis Allan Gray first reported a position in BHC in Q2 2013 and held it in 11 quarters. The position peaked at $484M in Q2 2014. 390 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

  • Orbis Allan Gray reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
  • Orbis Allan Gray sold 37,274 Bausch Health shares in Q1 2016, an estimated $3.79M.
  • Orbis Allan Gray first reported a position in Bausch Health in Q2 2013 and held it in 11 quarters.
  • Orbis Allan Gray's Bausch Health position peaked at $484M in Q2 2014.
  • 390 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Orbis Allan Gray's 13F filing for Q1 2016, filed 16 May 2016.